192 related articles for article (PubMed ID: 3086026)
1. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Pfaller M; Bale M; Preston T; Howard W; Koontz F
Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
4. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
[TBL] [Abstract][Full Text] [Related]
5. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.
Chan EL; Zabransky RJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):157-64. PubMed ID: 3102156
[TBL] [Abstract][Full Text] [Related]
6. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
[TBL] [Abstract][Full Text] [Related]
7. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Lerner SA; Dudek EJ; Boisvert WE; Berndt KD
Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769
[TBL] [Abstract][Full Text] [Related]
8. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
[No Abstract] [Full Text] [Related]
9. Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.
Braveny I; Machka K; Milatovic D
Eur J Clin Microbiol; 1986 Feb; 5(1):119-23. PubMed ID: 3084241
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Philippon A
Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
[TBL] [Abstract][Full Text] [Related]
11. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
Thabaut A; Durosoir JL; Meyran M
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
[TBL] [Abstract][Full Text] [Related]
12. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa.
Baltch AL; Bassey C; Hammer MC; Smith RP; Conroy JV; Michelsen PB
J Antimicrob Chemother; 1991 Jun; 27(6):801-8. PubMed ID: 1938686
[TBL] [Abstract][Full Text] [Related]
13. In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
Zinner SH; Blaser J
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():1-5. PubMed ID: 3086275
[TBL] [Abstract][Full Text] [Related]
14. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ansorg R; Müller KD; Wiora J
Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
Takahashi K; Kanno H
Antimicrob Agents Chemother; 1984 Nov; 26(5):789-91. PubMed ID: 6440482
[TBL] [Abstract][Full Text] [Related]
16. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Yamashiro Y; Ogake N; Takahata M; Minami S
Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
[TBL] [Abstract][Full Text] [Related]
17. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Rolston KV; Chandrasekar PH; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(1):31-4. PubMed ID: 6420119
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
20. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
